Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cure Pharmaceutical

Cure Pharmaceutical
2011 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
CURR STOCK SYMBOL
3 INVESTMENTS
$3.00 SHARE PRICE (As of Tuesday Closing)
Description

CURE Pharmaceutical Holding Corp is a developer and manufacturer of oral thin film. It offers development and manufacturing of Curefilm pharmaceutical and veterinarian products in patented and proprietary delivery system. It is presently focused on partnerships with pharmaceutical and biotech companies seeking to deliver drug actives utilizing its own proprietary Curefilm technology. It mainly operates in United States. The firm serves pharmaceutical, biotech, veterinarian, nutraceutical, medical food and cannabinoid drug molecules markets.

Ownership Status
Publicly Held
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
PINX
Primary Office
  • 1620 Beacon Place
  • Oxnard, CA 93033
  • United States

+1 (805) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cure Pharmaceutical’s full profile, request a free trial.

Cure Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.19 - $5.83 $114M $3.11 -$0.67 42.4K 38M

Cure Pharmaceutical Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 138,566 43,753 39,564
Revenue 518 584 180 84
EBITDA (16,362) (7,244) (6,417) (3,864)
Net Income (21,769) (10,400) (8,150) (4,157)
Total Assets 34,029 3,396 2,100 2,835
Total Debt 600 6,268 2,402 93
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cure Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cure Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Cure Pharmaceutical Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
QOL Medical Venture Capital-Backed Vero Beach, FL 00 00.00 000000000 00.00
00000000 Formerly PE-Backed Morristown, NJ 0000 000000&0
000000000 Corporation Stockholm, Sweden 0000 00000 00000000 00000
0000000 00000000 0 Corporate Backed or Acquired Hawthorn, Australia 00 000000&0
0000000000 0000000 Private Equity-Backed Sarasota, FL 00 000000000000
To view this company’s complete list of competitors, request access »

Cure Pharmaceutical Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 14-May-2019 000000000000000000 00000 Drug Delivery 000000 00000000
00000000 000000000 11-Jul-2018 000000000 00000 00 Buildings and Property 000000 00000000
CURE Pharmaceutical Holding 07-Nov-2016 Merger/Acquisition Paper/Soft Products
To view this company’s complete investment and acquisition history, request access »

Cure Pharmaceutical Executive Team (8)

Name Title Board
Seat
Contact
Info
Mark Udell Chief Financial Officer & Chief Accounting Officer
Michael Redard Chief Financial Officer
Jessica Rousset Chief Operating Officer
Vered Gigi Vice President, Strategy
Robert Davidson Chief Executive Officer & Board Member

3 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Cure Pharmaceutical Board Members (13)

Name Representing Role Since Contact
Info
Andrew Sturner JD Self Board Observer 000 0000
Dov Szapiro Self Board Observer 000 0000
Gene Salkind MD Self Board Member 000 0000
Ian Sephton Cure Pharmaceutical Board Member 000 0000
Joshua Held Cure Pharmaceutical Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »